David J Yvars Group Johnson & Johnson Transaction History

David J Yvars Group

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 11, 2024	SELL	$155.22 - $162.74 $5,898 - $6,184	-38 Reduced 2.91%	1,266 $200,000
Q3 2023 Oct 13, 2023	SELL	$155.75 - $174.48 $4,516 - $5,059	-29 Reduced 2.18%	1,304 $203,000
Q2 2023 Jul 10, 2023	SELL	$154.35 - $166.11 $771 - $830	-5 Reduced 0.37%	1,333 $220,000
Q1 2023 Apr 19, 2023	BUY	$151.05 - $180.26 $202,104 - $241,187	1,338 New	1,338 $207,000
Q4 2021 Jan 18, 2022	BUY	$155.93 - $173.01 $2.08 Million - $2.31 Million	13,355 New	13,355 $177,000

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of David J Yvars Group, based on Form 13F filings with the SEC.

Stay updated on David J Yvars Group with notifications on news.